Curtis Lockshin
2021
In 2021, Curtis Lockshin earned a total compensation of $508.3K as Chief Scientific Officer at Xenetic Biosciences, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $68,079 |
|---|---|
| Option Awards | $117,026 |
| Salary | $299,250 |
| Other | $23,965 |
| Total | $508,320 |
Lockshin received $299.3K in salary, accounting for 59% of the total pay in 2021.
Lockshin also received $68.1K in non-equity incentive plan, $117K in option awards and $24K in other compensation.
Rankings
In 2021, Curtis Lockshin's compensation ranked 10,688th out of 12,397 executives tracked by ExecPay. In other words, Lockshin earned more than 13.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,688 out of 12,397 | 14th |
Division Manufacturing | 4,713 out of 5,492 | 14th |
Major group Chemicals And Allied Products | 2,116 out of 2,367 | 11th |
Industry group Drugs | 1,882 out of 2,090 | 10th |
Industry Pharmaceutical Preparations | 1,392 out of 1,537 | 9th |
Source: SEC filing on October 17, 2022.
Lockshin's colleagues
We found two more compensation records of executives who worked with Curtis Lockshin at Xenetic Biosciences in 2021.